Lipoprotein(a) mass: A massively misunderstood metric
- 1 November 2014
- journal article
- review article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 8 (6) , 550-553
Abstract
No abstract availableKeywords
Funding Information
- Health Diagnostic Laboratory, Inc
This publication has 24 references indexed in Scilit:
- High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin TherapyCirculation, 2013
- Management of Lp(a)Journal of Clinical Lipidology, 2010
- Apolipoprotein(a) Isoforms and the Risk of Vascular DiseaseJACC, 2010
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary DiseaseNew England Journal of Medicine, 2009
- LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL managementJournal of Clinical Lipidology, 2007
- Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) methodClinical Biochemistry, 2004
- The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.Journal of Clinical Investigation, 1994
- Molecular definition of the extreme size polymorphism in apolipoprotein(a)Human Molecular Genetics, 1993
- The Mysteries Of Lipoprotein(a)Science, 1989
- Lipoprotein Lp(a) and the risk for myocardial infarctionAtherosclerosis, 1981